| ²é¿´: 1020 | »Ø¸´: 15 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û13´Î£¬×÷Õßgavin_yan83Ôö¼Ó½ð±Ò 11.5 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
[·ÖÏíÒ©¼ÁºÃÊé]Excipient Development for Pharmaceutical, Biotechnology, and DDS
|
||
|
Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems Informa Healthcare | ISBN: 0849327067 | 2006-07-28 | PDF | 452 pages | 4.29 Mb | RS To facilitate the development of novel drug delivery systems and biotechnology-oriented drugs, the need for new, yet to be developed, and approved excipients continues to increase. Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems serves as a comprehensive source to improve understanding of excipients and forge potential new avenues for regulatory approval. This book presents detailed, up-to-date information on various aspects of excipient development, testing, and technological considerations for their use. It addresses specific details such as historical perspective, preclinical testing, safety, and toxicology evaluation, as well as regulatory, quality, and utility aspects. The text also describes best practices for use of various functional excipients and extensive literature references for all topics. [ Last edited by gavin_yan83 on 2007-12-17 at 09:36 ] |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϹ¤³Ì302·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çó
ÒѾÓÐ3È˻ظ´
²ÄÁÏÓ뻯¹¤363ÇóÍÆ¼ö
ÒѾÓÐ4È˻ظ´
085602µ÷¼Á ³õÊÔ×Ü·Ö335
ÒѾÓÐ11È˻ظ´
081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ
ÒѾÓÐ12È˻ظ´
085410È˹¤ÖÇÄÜ ³õÊÔ316·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ11È˻ظ´
7Â¥2008-01-05 12:19:24
dnazyme
¾èÖú¹ó±ö (ÖªÃû×÷¼Ò)
- Ó¦Öú: 28 (СѧÉú)
- ¹ó±ö: 0.1
- ½ð±Ò: 2464.5
- Ìû×Ó: 6027
- ÔÚÏß: 2034.6Сʱ
- ³æºÅ: 35203
2Â¥2007-12-16 22:47:05
hongweiwei000
ÈÙÓþ°æÖ÷ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 2.28
- ½ð±Ò: 12313.9
- Ìû×Ó: 2249
- ÔÚÏß: 184.5Сʱ
- ³æºÅ: 420620
4Â¥2007-12-22 22:07:00
6Â¥2007-12-23 11:08:31














»Ø¸´´ËÂ¥
10